Business Allies Combine Efforts to Prevent Hospital Acquired Infections; PCTL Clarifies Testing Schedule for the U.K. and Announces Changes to Healthcare Market Website
LITTLE RIVER, S.C.--(BUSINESS WIRE)--Jan 16, 2020--
PCT LTD (OTC Pink: “PCTL”) announces a joint effort to market and distribute its wholly owned subsidiary’s (PCT Corp.’s) Annihilyzer® Infection Control System, clarifies the study period for the hospital trial and testing in the United Kingdom, and announces new healthcare market website.
PCT Corp.’s distributor/partner in the northeast, ACE Janitorial, has engaged an additional partner with many customers and expertise in supplying labor as a service company in the provision of cleaning and disinfecting systems and service in medical/healthcare/hospital facilities for the prevention of hospital acquired infections (HAI’s). The combined effort is to further promote PCT Corp.’s Annihilyzer® Infection Control Systems being deployed more quickly and to obtain more growth in this market. As a result of this new strategy, during the week of December 16 th, 2019 PCT Corp. installed another Annihilyzer® system in one of the Service Company’s facilities as a phase one installation and recently the Service Company provided required quick response professional assistance to a northeastern area healthcare facility using PCT Corp.’s Annihilyzer® System.
Gary Grieco, CEO of PCTL stated, “PCTL’s civic goals include being a good business community member and we stand willing to offer help to reduce and/or prevent HAI’s.” Grieco further commented, “Oftentimes lending assistance causes more business opportunities to develop, but that’s not the only reason we offer our professional staffs’ assistance along with our equipment’s solutions.”
The efficacy and efficiency studies of PCT Corp.’s Annihilyzer® Infection Control System, deployed in the United Kingdom, are slated to begin this week. Upon completion, comprehensive results are expected late in the 1 st quarter or early in the 2 nd quarter of this year.
PCT Corp. is in the process of moving away from the former healthcare focused website and is reinstituting the website into a domain name that better reflects its organizational structure now and for the future. Please visit www.pctcorphealth.com.
About PCT LTD
PCT LTD (“PCTL”) focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, “PCTL” aspires to and is actively engaged in preparations for uplisting its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
This press release contains “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.” Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT’s Annihilyzer® systems in hospitals in the U.S. or in the U.K.; the results of any manufacturers’ representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD’s and its subsidiary’s business prospects; PCT LTD’s ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer® Infection Control Systems, “high-volume” equipment or its suitability for market applications, Hydrolyte® generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200116005126/en/
Gary Grieco, CEO and Chairman of the Board
(843) 390-7900 Office
(843) 390-2347 Fax
www.survivalyte.comBrokers and Analysts:
KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA SOUTH CAROLINA
INDUSTRY KEYWORD: COMMERCIAL BUILDING & REAL ESTATE TECHNOLOGY MEDICAL DEVICES CONSTRUCTION & PROPERTY INFECTIOUS DISEASES HOSPITALS OTHER TECHNOLOGY BIOTECHNOLOGY HARDWARE HEALTH
SOURCE: PCT LTD
Copyright Business Wire 2020.
PUB: 01/16/2020 09:00 AM/DISC: 01/16/2020 09:01 AM